Abstract submission is an important part of the EHA-SWG Scientific Meeting on Integrated Cell Tracking in Oncohematology: Diagnosis, Targeted Therapy and Residual Disease. As a participant, you will have the opportunity to submit an abstract for this meeting, and (if accepted) have the possibility to discuss it with the international faculty and your peers. Abstract submission has been extended. Abstracts can now be submitted until the deadline of September 4, 2022 (23:59 CEST).
A selection of abstracts will be eligible for acceptance during the meeting, the presentation format will be in the form of oral presentations or poster presentations. Presenting authors will receive a separate invitation after the allocation notification has been sent to all abstract submitters. The corresponding authors will be informed of the allocation results as soon as possible.
You can submit an abstract or case on one of the following topics:
- Molecular hematology
- Acute and chronic leukemias
- Lymphoproliterative disorders/lymphomas
- Myelodysplastic syndromes
- Myeloproliterative neoplasms
- Multiple myeloma
- Paroxystic nocturnal hemoglobinuria
The abstracts will be reviewed and allocated by the Scientific Program Committee. Submitting authors will be informed about the allocation by September 16, 2022.
Please note that the submission of an abstract constitutes a formal commitment by the author to attend the meeting (if the abstract is accepted) and if required present the abstract as an oral presentation or poster presentation in the session and the time assigned by the Scientific Program Committee.
We therefore recommend that presenting authors of abstracts register for the meeting simultaneously with abstract submission. For more information about registration and to register, click here.
Should you have any questions, please contact email@example.com.